-
1
-
-
0029637266
-
Asthma - United States, 1982-1992
-
Asthma - United States, 1982-1992. MMWR 1995;43:952-5.
-
(1995)
MMWR
, vol.43
, pp. 952-955
-
-
-
2
-
-
0023223039
-
National trends in the morbidity and mortality of asthma in the US
-
Evans R III, Mullaly DI, Wilson RW, Gergen PJ, Rosenberg HM, Grauman JS, et al. National trends in the morbidity and mortality of asthma in the US. Chest 1987;91(suppl):65S-74S.
-
(1987)
Chest
, vol.91
, Issue.SUPPL.
-
-
Evans III, R.1
Mullaly, D.I.2
Wilson, R.W.3
Gergen, P.J.4
Rosenberg, H.M.5
Grauman, J.S.6
-
3
-
-
0028087957
-
Changing asthma mortality
-
Sly RM. Changing asthma mortality. Ann Allergy 1994;73:259-68.
-
(1994)
Ann Allergy
, vol.73
, pp. 259-268
-
-
Sly, R.M.1
-
4
-
-
0026566147
-
An economic evaluation of asthma in the United States
-
Weiss KB, Gergen PJ, Hodgson AT. An economic evaluation of asthma in the United States. N Engl J Med 1992;326:862-3.
-
(1992)
N Engl J Med
, vol.326
, pp. 862-863
-
-
Weiss, K.B.1
Gergen, P.J.2
Hodgson, A.T.3
-
5
-
-
0009882383
-
Current questions in the epidemiology of asthma
-
Holgate ST, Austen KF, Lichtenstein LM, Kay AB, editors. London: Academic Press
-
Burney PGJ. Current questions in the epidemiology of asthma. In: Holgate ST, Austen KF, Lichtenstein LM, Kay AB, editors. Asthma: physiology, immunopharmacology, and treatment. London: Academic Press; 1993. p. 3-25.
-
(1993)
Asthma: Physiology, Immunopharmacology, and Treatment
, pp. 3-25
-
-
Burney, P.G.J.1
-
6
-
-
0003522326
-
-
Bethesda (MD): National Institutes of Health (National Heart, Lung, and Blood Institute); NIH Publication number 91-3042A
-
National Asthma Education Program Expert Panel Report. Executive summary: guidelines for the diagnosis and management of asthma. Bethesda (MD): National Institutes of Health (National Heart, Lung, and Blood Institute); 1991. NIH Publication number 91-3042A.
-
(1991)
Executive Summary: Guidelines for the Diagnosis and Management of Asthma
-
-
-
7
-
-
85030303324
-
-
Bethesda (MD): National Institutes of Health (National Heart, Lung, and Blood Institute); NIH Publication number 95-3659
-
Global Initiative for Asthma. Global strategy for asthma management and prevention: NHLBI/WHO workshop report. Bethesda (MD): National Institutes of Health (National Heart, Lung, and Blood Institute); 1995. NIH Publication number 95-3659.
-
(1995)
Global Strategy for Asthma Management and Prevention: NHLBI/WHO Workshop Report
-
-
-
8
-
-
0029091338
-
Fluticasone propionate: An update on preclinical and clinical experience
-
Fuller R, Johnson M, Bye A. Fluticasone propionate: an update on preclinical and clinical experience. Respir Med 1995;89(suppl A):3-18.
-
(1995)
Respir Med
, vol.89
, Issue.SUPPL. A
, pp. 3-18
-
-
Fuller, R.1
Johnson, M.2
Bye, A.3
-
9
-
-
0025132348
-
The human pharmacology of fluticasone propionate
-
Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990;84(suppl A):25-9.
-
(1990)
Respir Med
, vol.84
, Issue.SUPPL. A
, pp. 25-29
-
-
Harding, S.M.1
-
10
-
-
0016824294
-
Beclomethasone dipropionate inhaler: A review of its pharmacology, therapeutic value and adverse effects. I
-
Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery GS. Beclomethasone dipropionate inhaler: a review of its pharmacology, therapeutic value and adverse effects. I. Asthma. Drugs 1975;10:166-210.
-
(1975)
Asthma. Drugs
, vol.10
, pp. 166-210
-
-
Brogden, R.N.1
Pinder, R.M.2
Sawyer, P.R.3
Speight, T.M.4
Avery, G.S.5
-
11
-
-
0021259193
-
Beclomethasone dipropionate: A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis
-
Brogden RN, Heel RC, Speight TM, Avery GS. Beclomethasone dipropionate: a reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs 1984;28:99-126.
-
(1984)
Drugs
, vol.28
, pp. 99-126
-
-
Brogden, R.N.1
Heel, R.C.2
Speight, T.M.3
Avery, G.S.4
-
12
-
-
0016190142
-
Treatment of asthma with triamcinolone acetonide delivered by aerosol
-
Williams MH Jr. Kane C. Shim CS. Treatment of asthma with triamcinolone acetonide delivered by aerosol. Am Rev Respir Dis 1974;109:538-43.
-
(1974)
Am Rev Respir Dis
, vol.109
, pp. 538-543
-
-
Williams Jr., M.H.1
Kane, C.2
Shim, C.S.3
-
13
-
-
0020084483
-
Efficacy and safety of triamcinolone acetonide aerosol in chronic asthma: Results of a multicenter, short-term controlled and long-term open study
-
Bernstein IL, Chervinsky P, Falliers CJ. Efficacy and safety of triamcinolone acetonide aerosol in chronic asthma: results of a multicenter, short-term controlled and long-term open study. Chest 1982;81:20-6.
-
(1982)
Chest
, vol.81
, pp. 20-26
-
-
Bernstein, I.L.1
Chervinsky, P.2
Falliers, C.J.3
-
14
-
-
0020028358
-
Flunisolide aerosol for treatment of severe, chronic asthma in steroid-independent children
-
Meltzer EO, Kemp JP, Orgel HA, Izu AE. Flunisolide aerosol for treatment of severe, chronic asthma in steroid-independent children. Pediatrics 1982;69:340-5.
-
(1982)
Pediatrics
, vol.69
, pp. 340-345
-
-
Meltzer, E.O.1
Kemp, J.P.2
Orgel, H.A.3
Izu, A.E.4
-
15
-
-
0019162224
-
Multicenter study of flunisolide aerosol in adult patients with steroid-dependent asthma
-
Slavin RG, Izu AE, Bernstein IL, Blumenthal MN, Bolin JF, Ovellette JJ, et al. Multicenter study of flunisolide aerosol in adult patients with steroid-dependent asthma. J Allergy Clin Immunol 1980;66:379-85.
-
(1980)
J Allergy Clin Immunol
, vol.66
, pp. 379-385
-
-
Slavin, R.G.1
Izu, A.E.2
Bernstein, I.L.3
Blumenthal, M.N.4
Bolin, J.F.5
Ovellette, J.J.6
-
16
-
-
0021796590
-
Comparison of budesonide and beclomethasone dipropionate in patients with severe chronic asthma: Assessment of relative prednisolone-sparing effects
-
Rafferty P, Tucker LG, Frame MH, Fergusson RJ, Biggs B-A, Crompton GK. Comparison of budesonide and beclomethasone dipropionate in patients with severe chronic asthma: assessment of relative prednisolone-sparing effects. Br J Dis Chest 1985;79:244-50.
-
(1985)
Br J Dis Chest
, vol.79
, pp. 244-250
-
-
Rafferty, P.1
Tucker, L.G.2
Frame, M.H.3
Fergusson, R.J.4
Biggs, B.-A.5
Crompton, G.K.6
-
17
-
-
0028846147
-
Fluticasone propionate aerosol reduces oral prednisone requirements while it improves control of asthma and quality of life
-
Noonan M, Chervinsky P, Busse WW, Weisberg SC, Pinnas J, deBoisblanc BP, et al. Fluticasone propionate aerosol reduces oral prednisone requirements while it improves control of asthma and quality of life. Am J Respir Crit Care Med 1995;152:1467-73.
-
(1995)
Am J Respir Crit Care Med
, vol.152
, pp. 1467-1473
-
-
Noonan, M.1
Chervinsky, P.2
Busse, W.W.3
Weisberg, S.C.4
Pinnas, J.5
DeBoisblanc, B.P.6
-
18
-
-
0007358950
-
Standardized methacholine challenge testing to demonstrate bio-equivalence of formulations of inhaled corticosteroids
-
Crescenzi KL, Wolfe J, Noonan M, Pinnas J, Kellerman DJ. Standardized methacholine challenge testing to demonstrate bio-equivalence of formulations of inhaled corticosteroids [abstract]. Ann Allergy Asthma Immunol 1996;74:64.
-
(1996)
Ann Allergy Asthma Immunol
, vol.74
, pp. 64
-
-
Crescenzi, K.L.1
Wolfe, J.2
Noonan, M.3
Pinnas, J.4
Kellerman, D.J.5
-
19
-
-
0030001876
-
Fluticasone propionate aerosol: Efficacy in patients with mild-to-moderate asthma
-
Sheffer AL, LaForce C, Chervinsky P, Pearlman D, Schaberg A, The Fluticasone Propionate Asthma Study Group. Fluticasone propionate aerosol: efficacy in patients with mild-to-moderate asthma. J Fam Pract 1996;42:369-75.
-
(1996)
J Fam Pract
, vol.42
, pp. 369-375
-
-
Sheffer, A.L.1
LaForce, C.2
Chervinsky, P.3
Pearlman, D.4
Schaberg, A.5
-
20
-
-
0028150916
-
Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma
-
Chervinsky P, van As A, Bronsky EA, Dockhorn R, Noonan M, La Force C, et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. J Allergy Clin Immunol 1994;94:676-83.
-
(1994)
J Allergy Clin Immunol
, vol.94
, pp. 676-683
-
-
Chervinsky, P.1
Van As, A.2
Bronsky, E.A.3
Dockhorn, R.4
Noonan, M.5
La Force, C.6
-
21
-
-
0028889036
-
Adverse effects of inhaled corticosteroids
-
Hanania NA, Chapman KR, Kesten S. Adverse effects of inhaled corticosteroids. Am J Med 1995;98:196-208.
-
(1995)
Am J Med
, vol.98
, pp. 196-208
-
-
Hanania, N.A.1
Chapman, K.R.2
Kesten, S.3
-
22
-
-
0028142363
-
Therapeutic controversies in the treatment of asthma
-
Kamada AK. Therapeutic controversies in the treatment of asthma. Ann Pharmacother 1994;28:904-14.
-
(1994)
Ann Pharmacother
, vol.28
, pp. 904-914
-
-
Kamada, A.K.1
-
23
-
-
0020386273
-
Development of new glucocorticosteroids with a very high ratio between topical and systemic activities
-
Brattsand R, Thalen A, Roempke K, Kallstrom L, Gruvstad E. Development of new glucocorticosteroids with a very high ratio between topical and systemic activities. Eur J Respir Dis 1982;63(suppl 122):62-73.
-
(1982)
Eur J Respir Dis
, vol.63
, Issue.122 SUPPL.
, pp. 62-73
-
-
Brattsand, R.1
Thalen, A.2
Roempke, K.3
Kallstrom, L.4
Gruvstad, E.5
-
24
-
-
84941818257
-
Method for comparing percutaneous absorption of steroids
-
McKenzie AW, Stoughton RB. Method for comparing percutaneous absorption of steroids. Arch Dermatol 1962;86:608-10.
-
(1962)
Arch Dermatol
, vol.86
, pp. 608-610
-
-
McKenzie, A.W.1
Stoughton, R.B.2
-
25
-
-
0028965413
-
A bioassay for topical and systemic effect of three inhaled corticosteroids
-
McCubbin MM, Milavetz G, Grandgeorge S, Weinberger M, Ahrens R, Sargent C, et al. A bioassay for topical and systemic effect of three inhaled corticosteroids. Clin Pharm Ther 1995;57:455-60.
-
(1995)
Clin Pharm Ther
, vol.57
, pp. 455-460
-
-
McCubbin, M.M.1
Milavetz, G.2
Grandgeorge, S.3
Weinberger, M.4
Ahrens, R.5
Sargent, C.6
-
26
-
-
0024332076
-
Bioequivalent doses of budesonide and prednisone in moderate and severe asthma
-
Toogood JH, Baskerville J, Jennings B, Lefcoe NM, Johansson AS. Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin Immunol 1989;84:688-700.
-
(1989)
J Allergy Clin Immunol
, vol.84
, pp. 688-700
-
-
Toogood, J.H.1
Baskerville, J.2
Jennings, B.3
Lefcoe, N.M.4
Johansson, A.S.5
-
27
-
-
0020431533
-
Comparison between inhaled and oral corticosteroids in patients with chronic asthma
-
Rosenhall L, Lundqvist G. Adelroth E, Glennow G. Comparison between inhaled and oral corticosteroids in patients with chronic asthma. Eur J Respir Dis 1982:63(suppl 122):62-73.
-
(1982)
Eur J Respir Dis
, vol.63
, Issue.122 SUPPL.
, pp. 62-73
-
-
Rosenhall, L.1
Lundqvist, G.2
Adelroth, E.3
Glennow, G.4
-
28
-
-
84865935940
-
-
Presented at the American Thoracic Society, New Orleans, LA, May 11-15
-
Gross G, Wolfe JD, Noonan MJ, Pinnas JL, Boltansky H, Nathan RA, et al. Fluticasone propionate 500 μg/day improves asthma more than triamcinolone acetonide 800 μg/day. Presented at the American Thoracic Society, New Orleans, LA, May 11-15, 1996.
-
(1996)
Fluticasone Propionate 500 μG/day Improves Asthma more than Triamcinolone Acetonide 800 μG/day
-
-
Gross, G.1
Wolfe, J.D.2
Noonan, M.J.3
Pinnas, J.L.4
Boltansky, H.5
Nathan, R.A.6
-
29
-
-
0023567409
-
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
-
American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
-
(1987)
Am Rev Respir Dis
, vol.136
, pp. 225-244
-
-
-
31
-
-
0019457107
-
Reference spirometric values using techniques and equipment that meet ATS recommendations
-
Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659-64.
-
(1981)
Am Rev Respir Dis
, vol.123
, pp. 659-664
-
-
Crapo, R.O.1
Morris, A.H.2
Gardner, R.M.3
-
33
-
-
0029736774
-
A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma
-
Wasserman SI, Gross GN, Schoenwetter WF, Munk ZM, Kral KM, Schaberg A, et al. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma. J Asthma 1996;33:265-74.
-
(1996)
J Asthma
, vol.33
, pp. 265-274
-
-
Wasserman, S.I.1
Gross, G.N.2
Schoenwetter, W.F.3
Munk, Z.M.4
Kral, K.M.5
Schaberg, A.6
-
34
-
-
0018203604
-
Clinical effect of aerosol triamcinolone acetonide in bronchial asthma
-
Grieco MH, Dwek J, Larsen K, Rammohan G. Clinical effect of aerosol triamcinolone acetonide in bronchial asthma. Arch Intern Med 1978;138:1337-41.
-
(1978)
Arch Intern Med
, vol.138
, pp. 1337-1341
-
-
Grieco, M.H.1
Dwek, J.2
Larsen, K.3
Rammohan, G.4
-
35
-
-
0027519906
-
Evaluation of fluticasone propionate (500 μg/day) administered either as dry powder via a Diskhaler® inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg/day) administered by pressurized inhaler
-
Lundback B, Alexander M, Day J, Hebert J, Holzer R, Van Uffelen R, et al. Evaluation of fluticasone propionate (500 μg/day) administered either as dry powder via a Diskhaler® inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg/day) administered by pressurized inhaler. Respir Med 1993;87:609-20.
-
(1993)
Respir Med
, vol.87
, pp. 609-620
-
-
Lundback, B.1
Alexander, M.2
Day, J.3
Hebert, J.4
Holzer, R.5
Van Uffelen, R.6
-
36
-
-
0030953465
-
Comparative efficacy and safety of twice-daily fluticasone propionate powder versus placebo in the treatment of moderate asthma
-
Pearlman DS, Noonan MJ, Tashkin DP, Goldstein MF, Hamedani AG, Kellerman DJ, et al. Comparative efficacy and safety of twice-daily fluticasone propionate powder versus placebo in the treatment of moderate asthma. Ann Allergy Asthma Immunol 1997;78:356-62.
-
(1997)
Ann Allergy Asthma Immunol
, vol.78
, pp. 356-362
-
-
Pearlman, D.S.1
Noonan, M.J.2
Tashkin, D.P.3
Goldstein, M.F.4
Hamedani, A.G.5
Kellerman, D.J.6
-
37
-
-
0030048729
-
Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids
-
Johnson M. Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol 1996;97:169-76.
-
(1996)
J Allergy Clin Immunol
, vol.97
, pp. 169-176
-
-
Johnson, M.1
-
38
-
-
0027376537
-
Efficacy and safety of inhaled corticosteroids in asthma
-
Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993;148:S1-S26.
-
(1993)
Am Rev Respir Dis
, vol.148
-
-
Barnes, P.J.1
Pedersen, S.2
-
39
-
-
0029864645
-
Trends in asthma therapy in the United States: 1965-1992
-
Terr AI, Bloch DA. Trends in asthma therapy in the United States: 1965-1992. Ann All Asthma Immunol 1996;76:273-81.
-
(1996)
Ann All Asthma Immunol
, vol.76
, pp. 273-281
-
-
Terr, A.I.1
Bloch, D.A.2
|